Komodo Health
-
Q4 Was Digital Health’s Worst Quarter for Funding in 5 Years
Digital health’s investment slowdown is so severe that the fourth quarter of 2022 marked the lowest quarterly digital health funding total in the past five years, according to new report. Q4 was also the first quarter with no new unicorn births since 2018.
-
Heard at HLTH: What’s on Healthcare Executives’ Agenda for 2023?
At the 5th annual HLTH conference in Las Vegas, 14 healthcare executives from companies such as Babson Diagnostics to Wheel responded to questions such as what’s the difference between a positive and negative user experience in telehealth? They also previewed their plans for 2023.
-
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
-
Are We in a Recession? Executives at HLTH Weigh In
MedCity News interviewed CEOs of public companies, entrepreneurs, VCs and payers at the HLTH conference that concluded last week. They had a range of answers to the question. But one common theme emerged: Currently, everyone has a vise-like grip on expenditure.
-
Experts Unpack the True Meaning Behind 3 Healthcare Buzzwords
A panel of healthcare data experts recently broke down some of healthcare’s most common buzzwords at HLTH. While the experts agreed that many industry professionals still struggle to grasp the true denotations of words and phrases like “interoperability” and “reimagining healthcare,” the panelists said these terms can be quite meaningful once they’re unpacked.
-
Vibe at ViVE: Health tech executives share new developments at inaugural conference
Hear from healthcare executives such as CVS Kidney Care President Lisa Rometty, Komodo Health CEO Dr. Arif Nathoo, and McKesson Ventures Partner Michelle Snyder on how they’re thinking about digital transformation in healthcare in a series of interviews at ViVE.
-
Mapping the digital future of pharma
Real-world data has long been touted as the solution to many challenges faced in the healthcare space – but more data doesn’t necessarily mean more answers. RWD has become the lynchpin to a more patient-centric approach to care, from drug development to therapy access and provider engagement. But until the tools and technology are in place to turn that data into actionable insights, in context, they’re nothing but numbers. Join us for a discussion on the crucial role of real world data and advanced analytics in the digital transformation of the life sciences industry.
-
BioPharma, Events, Health Services, Health Tech, SYN
INVEST Digital Health Preview: Mapping the Digital Future of Pharma
INVEST Digital Health is set for September 20-23, and held in collaboration with Medical Alley. The healthcare conference, held in a virtual format due to Covid-19, brings together innovative investors across the healthcare spectrum, prominent industry players and the most promising digital health startups.
-
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
-
INVEST Precision Medicine Conference Video: Software Supporting Biopharma R&D
This panel explores some of the diverse approaches companies are taking to improve efficiency and avert pitfalls in therapeutic development.
-
Events, Telemedicine, BioPharma
Clinical trials are undergoing a sea change thanks to telehealth, advanced data solutions
The clinical trial arena is changing rapidly, driven largely by the acceleration of telehealth usage and the potential provided by new data solutions. Panelists at MedCity INVEST Precision Medicine agreed that clinical trials will never be conducted in the same way again.
-
Day 2 of INVEST Precision Medicine: Life science startup pitches, biopharma software R&D, and more
Register for INVEST Precision Medicine to check out the life science track of the Pitch Perfect startup contest and hear compelling panel discussions on software supporting biopharma R&D, and the supply chain challenges of scaling production and delivering personalized therapies.
-
At INVEST Precision Medicine, a look at the software behind biopharma R&D
The conference, set for June 9-11, will explore different aspects of precision medicine, including the software being used to support drug and therapeutic development.
-
sponsored content, Artificial Intelligence
INVEST Video Conference: What is the role of AI in health equity?
With artificial intelligence and machine learning algorithms are becoming more in vogue in different aspects of healthcare, our panel discusses how can we ensure that AI is leveraged properly so that it advances the goals of health equity.
-
McKesson Ventures highlights investment priorities amidst a trail of successful exits
McKesson Ventures is one of the most active investors in the biopharma software sector with Komodo Health, Evidation and M2Gen among its portfolio companies.